Skip to main navigation
logo

Investor Navigation

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • SEC Filings
  • Governance
    • Documents & Charters
    • Board of Directors
    • Executive Team
    • Committee Composition
  • IR Resources
    • Investor FAQ
    • Contact IR
    • Email Alerts

Press Releases

27 May '2026
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
18 May '2026
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
06 May '2026
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
02 Apr '2026
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
23 Mar '2026
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
19 Mar '2026
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
09 Feb '2026
Context Therapeutics to Participate in Upcoming Investor Conferences
16 Jan '2026
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Investor Tools

  • Print Page
  • RSS Feeds
  • Search

© 2026 Context Therapeutics Inc.     All rights reserved.